NGNE   $54.4  3.27% Market Closed After Close 54.4 0.0

Neurogene Inc
Total Cash 153.90M
totalCashPerShare 11.845
EBITDA -65.47M
Total Debt 13.79M
quickRatio 11.822
currentRatio 12.174
Total Revenue 925.00K
debtToEquity 8.893
Revenue/Share 0.106
ROA -0.32361
ROE -0.41339
grossProfits
freeCashflow -34.07M
operatingCashflow -66.08M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -21.766489
profitMargins 0.0
enterpriseValue 551.85M
forwardPE -11.860803
floatShares 5.08M
sharesOutstanding 12.99M
sharesShort 1.90M
sharesShortPriorMonth 1.82M
dateShortInterest
sharesPercentSharesOut 0.15%
heldPercentInsiders 0.11%
heldPercentInstitutions 1.02%
Short Ratio help_outline 17.09%
shortPercentOfFloat 0.16%
impliedSharesOutstanding
bookValue 11.934
Price To Book help_outline 4.46
earningsQuarterlyGrowth
netIncomeToCommon 2.36M
trailingEps -3.66%
forwardEps -4.49%
enterpriseToEbitda -8.43
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.22 3Q 2024
institutionsCount 106
lastUpdated Oct. 17, 2024, 4:11 p.m.